1. Medtech Insight

AdvaMed White Paper Advises Systemic Medicare Coverage For Digital Technology

Changes in reimbursement could be achieved through existing regulatory authorities, industry says

 
• By Sue Darcey

The medtech industry advocacy group issued a white paper on best methods for Medicare coverage of telehealth, remote patient monitoring and other digital technology.

Professional doctor in a smartphone giving a consultation online and checking a radiography, telemedicine and healthcare concept, blank copy space

Medicare coverage for digital health medtech such as telemedicine should be modernized to support these labor- and cost-saving technologies, says a new industry white paper released on 1 October.

Sponsored by industry advocacy group AdvaMed and authored by Washington, DC, health policy consulting group CapView Strategies, the “Modernizing Medicare Coverage Of Digital Health Technologies” white paper points to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.